Immune system study in IgG4-related tear gland disease
Part of Immune system & allergy clinical trials.
This study looks at how the immune system (specifically T cells) works in people with IgG4-related disease affecting the tear glands. It aims to understand why the immune system becomes overactive, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have swelling of the tear glands (lacrimal glands) due to IgG4-related disease.
- Your blood IgG4 level is above 135 mg/dL.
- A biopsy of your tear gland shows signs of IgG4-related inflammation.
- You do not have other autoimmune diseases like Sjögren's, lupus, or rheumatoid arthritis.
- Your condition is not caused by other eye diseases like MALT lymphoma or inflammatory pseudotumor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a study that follows people diagnosed with IgG4-related disease to better understand the condition. It may help researchers confirm diagnoses and learn how the disease affects different organs over time.
This study looks at a specific immune signal (C5a/C5aR1) in IgG4-related disease to see if blocking that signal could be a future treatment. It compares blood samples from people with active disease, people in remission, and healthy volunteers.
This trial tests a new drug called ACE1831 for people with active IgG4-related disease that affects more than one organ. It aims to see if the drug can safely control the disease and reduce the need for steroids.
This trial tests a short course of steroids combined with mycophenolate mofetil (MMF) for people with active IgG4-related disease who have not been treated before or whose disease came back after stopping treatment. The goal is to see if this combination helps control the disease better.
This trial tests a new medicine called IMM0306 for IgG4-related disease, a condition where the immune system attacks multiple organs in your body. The study aims to see if IMM0306 can help control your disease and reduce flare-ups while using less steroid medication.
This trial tests a new eye drop made from a natural protein (rhPRG4) to see if it safely and effectively relieves dry eye symptoms in people with Sjögren's syndrome. You'll be randomly assigned to receive the study drop or a placebo (inactive) drop for several weeks.
Hear when a new IgG4-Related Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.